Pages that link to "Q34287662"
Jump to navigation
Jump to search
The following pages link to Cancer genetics and epigenetics: two sides of the same coin? (Q34287662):
Displaying 50 items.
- JARID1B is a luminal lineage-driving oncogene in breast cancer (Q24299326) (← links)
- Targeting the epigenome in lung cancer: expanding approaches to epigenetic therapy (Q24609974) (← links)
- Epigenetic therapy in gastrointestinal cancer: the right combination (Q26745709) (← links)
- MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma (Q26765476) (← links)
- Dysregulated metabolism contributes to oncogenesis (Q26784630) (← links)
- Alteration of Epigenetic Profile in Human Hepatocellular Carcinoma and Its Clinical Implications (Q26797616) (← links)
- Epigenetic modifications in colorectal cancer: molecular insights and therapeutic challenges (Q26823070) (← links)
- DNA methylation in mammals (Q26852141) (← links)
- HDAC inhibitors and immunotherapy; a double edged sword? (Q26853102) (← links)
- Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial (Q27015838) (← links)
- Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer (Q27022720) (← links)
- Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma (Q27025984) (← links)
- 8-Substituted Pyrido[3,4-d]pyrimidin-4(3H)-one Derivatives As Potent, Cell Permeable, KDM4 (JMJD2) and KDM5 (JARID1) Histone Lysine Demethylase Inhibitors (Q27644640) (← links)
- Comparison of the Structural and Dynamic Effects of 5-Methylcytosine and 5-Chlorocytosine in a CpG Dinucleotide Sequence (Q27680423) (← links)
- Epigenetic Therapeutics: A New Weapon in the War Against Cancer (Q28072370) (← links)
- Genetic and Epigenetic Alterations in Bladder Cancer (Q28074732) (← links)
- The Emergence of Pan-Cancer CIMP and Its Elusive Interpretation (Q28075374) (← links)
- Insights for hepatitis C virus related hepatocellular carcinoma genetic biomarkers: Early diagnosis and therapeutic intervention (Q28080281) (← links)
- DNA methylation, its mediators and genome integrity (Q28080760) (← links)
- Visualizing posttranslational and epigenetic modifications of endogenous proteins in vivo (Q28083442) (← links)
- The role of piRNA and its potential clinical implications in cancer (Q28083603) (← links)
- Epigenome-based personalized medicine in human cancer (Q28083951) (← links)
- Epigenetic regulation of Keap1-Nrf2 signaling (Q28084220) (← links)
- Epigenetic regulation of the intestinal epithelium (Q28084849) (← links)
- Transgenerational effects of obesogens and the obesity epidemic (Q28385988) (← links)
- Epithelial cancers in the post-genomic era: should we reconsider our lifestyle? (Q28391921) (← links)
- Properly substituted analogues of BIX-01294 lose inhibition of G9a histone methyltransferase and gain selective anti-DNA methyltransferase 3A activity (Q28538629) (← links)
- Selective inhibition of tumor oncogenes by disruption of super-enhancers (Q29617301) (← links)
- Combattre les maladies négligées en ciblant sélectivement leurs enzymes épigénétiques : le cas de la désacétylase 8 (HDAC8) de Schistosoma mansoni (Q30315847) (← links)
- Investigating Effects of Acidic pH on Proliferation, Invasion and Drug-Induced Apoptosis in Lymphoblastic Leukemia. (Q30363892) (← links)
- Detection of histone modifications at specific gene loci in single cells in histological sections (Q30417984) (← links)
- Radiation risks associated with serial imaging in colorectal cancer patients: should we worry? (Q30444573) (← links)
- ChromoHub V2: cancer genomics (Q30486546) (← links)
- The mutational landscape of chromatin regulatory factors across 4,623 tumor samples (Q30580509) (← links)
- Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data (Q30887798) (← links)
- PINCAGE: probabilistic integration of cancer genomics data for perturbed gene identification and sample classification (Q31035683) (← links)
- A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors (Q33410836) (← links)
- A phase I trial of panobinostat (LBH589) in patients with metastatic melanoma. (Q33436058) (← links)
- The recurrence risk of genetic complex diseases (Q33561021) (← links)
- Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia (Q33585130) (← links)
- Methylation pattern of preferentially expressed antigen of melanoma in acute myeloid leukemia and myelodysplastic syndromes (Q33597549) (← links)
- Thymic Epithelial Tumors phenotype relies on miR-145-5p epigenetic regulation (Q33655180) (← links)
- The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer (Q33705036) (← links)
- Epigenetic reprogramming modulates malignant properties of human liver cancer. (Q33707196) (← links)
- Revisiting the hallmarks of cancer (Q33732986) (← links)
- Epigenetic Regulation of Telomere Maintenance for Therapeutic Interventions in Gliomas. (Q33737472) (← links)
- Epigenetics and pancreatic cancer: pathophysiology and novel treatment aspects (Q33801377) (← links)
- Mutant TP53 posttranslational modifications: challenges and opportunities. (Q33818479) (← links)
- High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma (Q33845409) (← links)
- Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance. (Q33920767) (← links)